The use of metal-organic frameworks functionalised with engineered antibody fragments for targeted therapies
Repository URI
Repository DOI
Change log
Authors
Abstract
[Restricted]
Description
Date
2021-09-01
Advisors
Fairen-Jimenez, David
Ravn, Peter
Ravn, Peter
Qualification
Doctor of Philosophy (PhD)
Awarding Institution
University of Cambridge
Rights and licensing
Except where otherwised noted, this item's license is described as All Rights Reserved
Sponsorship
EPSRC (1783588)
EPSRC (Grant EP/L015889/1) and AstraZeneca